Patent Assignment
Reel/Frame 051016/0081
Security Interest
Recorded: 2019-11-15
Pages: 6
Assignor
ABEXXA BIOLOGICS, INC.
Executed: 2019-11-15
Assignee
BOEHRINGER INGELHEIM VENTURE FUND USA, INC.
1 BROADWAY, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(4)
Methods and Compositions for Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen in Cancer
PCT:
PCT/US2018/015086 ↗
Combination Cancer Therapy with Anti-Cancer Agents and Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen
PCT:
PCT/US2019/019295 ↗
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
PCT:
PCT/US2019/043108 ↗
Methods and Compositions for Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen in Cancer
Application:
16/103,764 →
Publication:
US 2019/0071502
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 23, 2018
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 046683/0927 →
Assignment of Assignor's Interest
Jun 13, 2019
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 049459/0299 →
Assignment of Assignor's Interest
Sep 22, 2020
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 053846/0249 →
Assignment of Assignor's Interest
Apr 6, 2021
From: WEIDANZ, JON
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 055843/0090 →
Merger
Jan 6, 2022
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 058584/0680 →
Assignment of Assignor's Interest
Nov 1, 2022
From: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 061615/0332 →